Cancer vaccine white paper from Frost and Sullivan industry experts

1 March 2022
Posted in News | Tagged , ,

In this white paper, brought to you by BioRad, hear from leading industry experts in the emerging field of cancer vaccines.

The experts discuss:

  • Challenges related to antigen and adjuvant selection
  • Vaccine design
  • Immune response improvement
  • Future treatment options

Download the white paper here.

Suggested Reading

mRNA technology may hold the future for a cytomegalovirus vaccine 
28 September 2022
How big data analytics can make personalised care a reality
6 February 2023

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free